Psycho-social factors associated with type two diabetes remission through lifestyle intervention: A scoping review.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Hart KJ;Hart KJ; Kubilius A; Kubilius A; Clark M; Clark M
  • Source:
    PloS one [PLoS One] 2023 Nov 16; Vol. 18 (11), pp. e0294344. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
  • Publication Type:
    Review; Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Objectives: There is growing evidence that type 2 diabetes (T2D) can be put into remission through lifestyle intervention. Current focus on remission in terms of physiological considerations and biomedical scales, means there is limited understanding of the role psycho-social factors play in moderating the efficacy of lifestyle interventions for T2D remission. In the current review we aimed to synthesise the emerging literature on psycho-social factors associated with T2D remission, specifically from lifestyle interventions.
      Methods: Five databases (EMBASE, MEDLINE, CINAHL ultimate, PsychINFO and PsycArticles) were searched to identify studies from 2009 onwards that reported remission outcomes from lifestyle interventions in participants ≥ 18years old, with a clinical diagnosis of T2D. Studies included were of an interventional or observational design and restricted to English language. Screening and data extraction was performed independently by two reviewers using prespecified criteria.
      Results: In total 6106 studies were screened, 36 studies meeting the inclusion criteria were included. Studies were globally diverse, with 30 (83%) being published ≥ 2017. Psycho-social scales were under-utilised with 22 (67%) of studies failing to include any psycho-social measures. Single arm, prospective studies were most frequently utilised, however study quality was perceived to be heterogeneous. Further disparity in the quality, content and delineation of the psycho-social interventions was also identified. Education and self-monitoring interventions were the most frequently incorporated. Self-monitoring was also identified as an important facilitator to remission, in addition to social support.
      Conclusions: Our findings indicate that psycho-social factors in T2D remission are under-explored. We have identified a number of methodological issues (comparability, conflicting remission criteria and poorly defined psycho-social interventions) suggesting knowledge gaps which could inform the methodology of future research design. There is significant opportunity for future research to incorporate the social model of disease, conceptualise remission more holistically, and build a more comprehensive evidence base to guide clinical practice.
      Competing Interests: The authors have declared that no competing interests exist.
      (Copyright: © 2023 Hart et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      Patient Educ Couns. 2016 Jul;99(7):1233-1239. (PMID: 27873575)
      Psychol Health. 2011 Nov;26(11):1479-98. (PMID: 21678185)
      Diabetes Metab Syndr Obes. 2019 Dec 05;12:2567-2582. (PMID: 31827331)
      Front Endocrinol (Lausanne). 2019 Jun 05;10:348. (PMID: 31231311)
      Ann Intern Med. 2018 Oct 2;169(7):467-473. (PMID: 30178033)
      PLoS One. 2018 Oct 18;13(10):e0204890. (PMID: 30335780)
      Diabet Med. 2019 Mar;36(3):308-315. (PMID: 30378706)
      Am J Clin Nutr. 2018 Aug 1;108(2):300-331. (PMID: 30007275)
      Indian J Endocrinol Metab. 2017 Sep-Oct;21(5):776-780. (PMID: 28989891)
      Int J Nurs Sci. 2019 Sep 06;6(4):468-477. (PMID: 31728402)
      Diabetes Res Clin Pract. 2018 Mar;137:28-36. (PMID: 29278711)
      Diabet Med. 2020 Nov;37(11):1816-1824. (PMID: 31365159)
      Chronic Illn. 2010 Sep;6(3):202-14. (PMID: 20675362)
      JBI Evid Synth. 2020 Oct;18(10):2119-2126. (PMID: 33038124)
      JMIR Diabetes. 2022 Feb 23;7(1):e34465. (PMID: 35050857)
      Diabetes Educ. 2007 Mar-Apr;33(2):273-81. (PMID: 17426302)
      Diabetes Care. 1995 Jun;18(6):754-60. (PMID: 7555499)
      J Cardiopulm Rehabil Prev. 2015 May-Jun;35(3):193-7. (PMID: 25636149)
      JAMA Intern Med. 2020 Jan 1;180(1):70-79. (PMID: 31682682)
      Diabet Med. 2021 Aug;38(8):e14395. (PMID: 32870520)
      J Med Internet Res. 2022 Feb 2;24(2):e31184. (PMID: 35107429)
      Diabet Med. 2020 Jun;37(6):953-962. (PMID: 31269276)
      Can J Diabetes. 2022 Dec;46(8):753-761.e8. (PMID: 36567079)
      Obesity (Silver Spring). 2013 Sep;21(9):1789-97. (PMID: 23512320)
      Diabet Med. 2020 Feb;37(2):242-247. (PMID: 31901175)
      Diabetologia. 2018 Feb;61(2):273-283. (PMID: 29143063)
      BMJ. 2021 Mar 29;372:n71. (PMID: 33782057)
      BJOG. 2018 Dec;125(13):1716. (PMID: 29916205)
      BMC Fam Pract. 2013 May 24;14:66. (PMID: 23705978)
      BMC Fam Pract. 2018 Mar 9;19(1):39. (PMID: 29523075)
      Nutrients. 2021 Jun 25;13(7):. (PMID: 34202194)
      Lancet. 2018 Feb 10;391(10120):541-551. (PMID: 29221645)
      Diabetes Care. 2009 Nov;32(11):2133-5. (PMID: 19875608)
      PLoS Med. 2020 Oct 28;17(10):e1003396. (PMID: 33112845)
      Fam Community Health. 2013 Apr-Jun;36(2):158-71. (PMID: 23455686)
      Diabetes Res Clin Pract. 2019 Nov;157:107843. (PMID: 31518657)
      Qual Life Res. 2020 Nov;29(11):3119-3129. (PMID: 32648198)
      Prim Care Diabetes. 2019 Dec;13(6):556-567. (PMID: 31040069)
      Psychol Res Behav Manag. 2019 Jan 29;12:67-79. (PMID: 30774486)
      Diabetes Care. 2016 May;39(5):808-15. (PMID: 27002059)
      Diabetes Obes Metab. 2019 Oct;21(10):2257-2266. (PMID: 31168922)
      Diabet Med. 2022 Jan;39(1):e14689. (PMID: 34519099)
      Food Sci Nutr. 2019 Feb 11;7(3):1113-1122. (PMID: 30918654)
      Nutrients. 2022 Jul 30;14(15):. (PMID: 35956322)
      Diabetes Educ. 2008 Mar-Apr;34(2):266-76. (PMID: 18375776)
      PLoS One. 2020 Apr 8;15(4):e0231291. (PMID: 32267893)
      J Diabetes Investig. 2023 Mar;14(3):351-353. (PMID: 36625268)
      Diabetes Educ. 2012 Jan-Feb;38(1):77-85. (PMID: 22222514)
      JAMA. 2012 Dec 19;308(23):2489-96. (PMID: 23288372)
      Lancet Diabetes Endocrinol. 2019 May;7(5):344-355. (PMID: 30852132)
      Diabetologia. 2019 Jun;62(6):877-887. (PMID: 30963188)
      Obes Sci Pract. 2021 May 15;7(5):606-618. (PMID: 34631138)
      Diabetologia. 2022 Feb;65(2):406-408. (PMID: 34778926)
      J Exp Stroke Transl Med. 2010 Feb 9;3(1):8-18. (PMID: 21423788)
      Diabet Med. 2023 Mar;40(3):e15016. (PMID: 36440921)
      Int J Epidemiol. 2002 Dec;31(6):1091-3. (PMID: 12540696)
      Diabet Med. 2019 Aug;36(8):1003-1012. (PMID: 31026353)
      BMJ Nutr Prev Health. 2020 Nov 02;3(2):285-294. (PMID: 33521540)
      Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):300-306. (PMID: 28274728)
      Diabetes Res Clin Pract. 2022 Jan;183:109119. (PMID: 34879977)
      Diabetes Educ. 2013 Jan-Feb;39(1):33-52. (PMID: 23073967)
      Diabetes Care. 2005 Mar;28(3):626-31. (PMID: 15735199)
      Ann Palliat Med. 2022 Apr;11(4):1462-1472. (PMID: 35523754)
      Cardiovasc Endocrinol Metab. 2020 May 25;9(4):132-142. (PMID: 33225228)
      BMC Public Health. 2016 May 04;16:371. (PMID: 27142984)
      Diabet Med. 2017 Nov;34(11):1554-1567. (PMID: 28727247)
      Diabetes Care. 2016 Dec;39(12):2126-2140. (PMID: 27879358)
      Br J Diabetes. 2022 Jun;22(1):20-29. (PMID: 36045887)
      Diabetologia. 2016 May;59(5):945-53. (PMID: 26983924)
      J Diabetes Investig. 2022 Jan;13(1):156-166. (PMID: 34176234)
      Obesity (Silver Spring). 2018 Dec;26(12):1866-1867. (PMID: 30417975)
      Diabet Med. 2016 May;33(5):580-91. (PMID: 26490082)
      BMJ Open Diabetes Res Care. 2017 Feb 23;5(1):e000354. (PMID: 28316796)
      J Adv Nurs. 1999 Aug;30(2):352-9. (PMID: 10457237)
      Diabet Med. 2019 Dec;36(12):1532-1538. (PMID: 31177573)
      Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1475-1479. (PMID: 31336509)
      PLoS One. 2020 May 13;15(5):e0232250. (PMID: 32401778)
      Diabetes Care. 2021 Aug 30;:. (PMID: 34462270)
      BMJ. 2021 Jan 13;372:m4743. (PMID: 33441384)
      Nurse Res. 2011;18(3):32-6. (PMID: 21560924)
      BMC Med Res Methodol. 2011 Jun 27;11:100. (PMID: 21707982)
      Lancet Diabetes Endocrinol. 2020 Jun;8(6):477-489. (PMID: 32445735)
      Curr Opin Endocrinol Diabetes Obes. 2021 Oct 1;28(5):463-468. (PMID: 34468401)
      Diabet Med. 2013 Jul;30(7):767-77. (PMID: 23711019)
    • Publication Date:
      Date Created: 20231116 Date Completed: 20231127 Latest Revision: 20231127
    • Publication Date:
      20240628
    • Accession Number:
      PMC10653481
    • Accession Number:
      10.1371/journal.pone.0294344
    • Accession Number:
      37972024